- Stocks Telegraph
- Posts
- 15 Nov - Morning Newsletter (with changes)
15 Nov - Morning Newsletter (with changes)
Today's Top-4 Premarket Stocks
Good Morning!
The US stock indices did not have a great week. Friday was about the only day we saw a recovery. The S&P 500 climbed 0.72 percent to 4,683 points and Laboratory Corp. Of America was the strongest stock in the index with a daily result of plus 3.61%. Nasdaq 100 won 1.04% and ended the week at 16,200 points. Fastned and Facebook were the strongest stocks, up 4.33% and 4.01% respectively. The Dow Jones Industrial Average rose 0.50% with a closing price of 36,100 points. 3M led the way with a green 1.91% on the plates.It was one of the worst weeks in a long time for Tesla shareholders. Shares of Tesla lost another 2.83% last Friday. Financial reporting shows that Elon Musk sold about $6.9 billion of Tesla stock last week.
"Forever Dividends" Stock List
6 stocks make up our compound income portfolio, which yields 24 dividend payments a year. Claim our free investment report which details 6 companies in our Forever Dividend Stocks.
Today Top Movers
Creative Realities Inc. (CREX)
stock soared 102.05% to $2.95 in the pre-market trading as the firm announced the merger with Reflect Systems, Inc.
EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT)
shares are trading up 42.76% at $20.0 at the time of writing after company reported six-month interim data from the "Durasert® and Vorolanib in Ophthalmology" (DAVIO) Phase 1 clinical trial of EYP-1901. Company’s 52-week ranged between $3.90 to $16.27. Analysts have a consensus price target of $25.
NanoViricides, Inc. (NNVC)
grew over 10.28% at $5.15 in pre-market trading today soon after the firm announced that it has developed oral gummies formulations of its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 to benefit non-hospitalized patients.
Oxbridge Re Holdings Limited (OXBR)
, a Insurance - Reinsurance company, rose about 16.53% at $4.16 in pre-market trading Monday. The firm reported improved results for the three and nine months ended September 30, 2021.
Quickest Path to Riches in the 2021 Gold Bull Market Revealed
Gold is booming and smart investors are already cashing in on the #1 Gold Investment of 2021. Yet, you haven't missed the boat. As the Biden administration blows up the federal deficit with $6 Trillion in spending, gold will be the biggest beneficiary as inflation soars.
Top Upgrades & Downgrades
UBS turned bullish on Chevron Corporation (CVX), upgrading the stock to "Buy" and assigning a $125.00 price target, representing potential upside of 8.62% from Monday's close.
Blink Charging Co. (BLNK) has won the favor of HC Wainwright & Co. equity research team. The firm upgraded the shares from Neutral to BUY and moved their price target to $50, suggesting 24.97% upside potential for the stock.
Penn National Gaming Inc. (PENN) received an upgrade from analysts at Deutsche Bank. They changed their rating on PENN to Hold from Sell in a recently issued research note.
Earlier Goldman Sachs reduced its rating on TG Therapeutics Inc. (TGTX) stock to Sell from Netural and assigned the price target to $26. With shares trading at around $31.78, the Wall Street firm thinks TG Therapeutics Inc.'s stock could down 18.19%.
Goldman Sachs analysts reduced their investment ratings, saying in research reports covered by the media that its rating for BioXcel Therapeutics Inc. (BTAI) has been changed to Sell from Buy and the new price target is set at $24.
Analysts at Goldman Sachs downgraded National Vision Holdings Inc. (EYE)'s stock to Neutral from Buy.
Gold Discovery: US$0.25 Gold Stock Set to Deliver Gains
Gold & copper are rising! And smart investors are loading up on a tiny mining firm trading undiscovered by Wall St below 25 cents a share. Led by an incredible team of mining professionals, this upstart firm is already hitting high-grade gold-copper with every turn of the drill. It's one of those rare opportunities where the next drill hole could send the company's shares upward by several-fold.
Latest Insider Activity
Pfizer Inc. (PFE) Group President YOUNG JOHN D announced the sale of shares taking place on Nov 11 at $50.06 for some 150,000 shares. The total came to more than $7.51 million.
Tesla Inc. (TSLA) CEO Musk Elon sold on Nov 12 a total 166,285,682 shares at $1029.67 on average. The insider’s sale generated proceeds of almost $1.24 billion.
Exela Technologies Inc. (XELA) Director BEILINSON MARC A declared the purchase of shares taking place on Nov 11 at $1.61 for some 100,000 shares. The transaction amount was around $0.16 million.
MoneyGram International Inc. (MGI) Director TURNER W BRUCE bought on Nov 11 a total 544,575 shares at $5.59 on average. The purchase cost the insider an estimated $489,125.
Forbes mag says this strategy "like finding money in the street"
And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.
Important Earnings
Top US earnings releases scheduled for today include TAL Education Group (NYSE:TAL). It will announce its May 2021 financial results. The company is expected to report earnings of $0.01 per share from revenues of $1.31B in the three-month period.
Analysts expect Fang Holdings Limited (NYSE:SFUN) to report a net income (adjusted) of $0 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Jun 2019 is predicted to come in at $67.56M.
Adamis Pharmaceuticals Corporation (ADMP), due to announce earnings after the market closes today, is expected to report earnings of $0 per share from revenues of $3.47M recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.